BWI: Unichem Laboratories Receives ANDA Approval from USFDA for Hydrochlorothiazide Capsules

Press release from Business Wire India
Source: Unichem Laboratories Limited
Wednesday, January 20, 2010 05:41 PM IST (12:11 PM GMT)
Editors: Business: Advertising, PR & marketing, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
Unichem Laboratories Receives ANDA Approval from USFDA for Hydrochlorothiazide Capsules


Mumbai, Maharashtra, India, Wednesday, January 20, 2010 -- (Business Wire India) -- Unichem laboratories Limited pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (U.S. FDA) for Hydrochlorothiazide Capsules in the strengths of 12.5 mg

Hydrochlorothiazide is a thiazide diuretic used in the management of edema and hypertension. In hypertension, thiazide diuretics are often used as initial therapy, either alone or in combination with other agents.

Hydrochlorothiazide's innovator is Novartis-Global and appears world-wide under the brand names: Esidrix, HydroDIURIL, Microzide and Oretic

About Unichem Laboratories Limited

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, and orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms.

More information about the company can be found at www.unichemindia.com


CONTACT DETAILS
Mr. K Subharaman, Unichem Laboratories Limited, +91 (22) 66888404 / +919833031121, subharamank@unichemindia.com
Mr. Rakesh Parikh, Unichem Laboratories Limited, +91(22) 66888414 / +919892925555, rparikh@unichemindia.com
Mr. M Gundu Rao, Unichem Laboratories Limited, +91(22) 66888380 / +919820228944, gundurao@unichemindia.com

KEYWORDS
MARKETING, HEALTHCARE, HEALTHCARE, UNICHEMLAB.BO, UNICHEMLAB.NS

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com